Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma, Kaposi 2Sarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Melanoma 2Hemangioma, Capillary 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Lymphatic Metastasis 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Specimen Handling 8pembrolizumab 7enfortumab vedotin 7Magnetic Resonance Spectroscopy 6avelumab 4Nivolumab 4Gemcitabine 3cabozantinib 2Ipilimumab 2Immunoglobulin G 2Disulfides 2Cisplatin 2Carboplatin 2CTLA-4 Antigen 2Biopsy 2vinflunine 1tremelimumab 1tocilizumab 1tamibarotene 1relatlimab 1eribulin 1erdafitinib 1durvalumab 1copanlisib 1atezolizumab 1Watchful Waiting 1Standard of Care 1Propranolol 1Practice Guidelines as Topic 1Plasmapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ureteral Neoplasms × Propranolol × 1 year × Clear all
NCT04848519 2026-02-19

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma

Emory University

Phase 2 Active not recruiting
6 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡